LONDON - Eden Research plc (AIM:EDEN), a company specializing in sustainable biopesticide and biocontrol technology, announced that it will be hosting a live presentation for its full year results on May 14, 2025. The event, scheduled for 14:00 BST, will feature CEO Sean Smith and CFO Alex Abrey, and is open to all current and prospective shareholders.
The presentation will be conducted via Investor Meet Company, a platform that facilitates interactive meetings between investors and companies. Shareholders interested in attending can sign up for free and submit questions in advance until May 13, 2025, at 09:00 BST or during the live event.
Eden Research is recognized as the only UK-listed company focusing exclusively on biopesticides for sustainable agriculture. Their product lineup includes Mevalone®, a biofungicide for grapes and other high-value crops, NovellusÒ+, an enhanced version of Mevalone, and Cedroz™, a bionematicide targeting parasitic nematodes. Additionally, Eden has introduced Ecovelex™, a seed treatment product designed to deter birds from destroying crops.
The company’s proprietary Sustaine® microencapsulation technology is highlighted as a significant innovation, providing a biodegradable and plastic-free solution for delivering plant-derived active ingredients more effectively.
Eden Research’s commitment to sustainability is further exemplified by its receipt of the London Stock Exchange (LON:LSEG) Green Economy Mark in January 2021, an acknowledgment of companies generating over 50% of their revenue from green products and services. Eden boasts that 100% of its revenue is derived from sustainable offerings.
The announcement of the presentation comes as part of the company’s ongoing efforts to keep its investors informed and engaged in its operations and strategic direction. The information provided is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.